Elser Financial Planning’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Buy
8,544
+23
+0.3% +$5.36K 0.09% 36
2026
Q1
$2.1M Buy
8,521
+1
+0% +$233 0.1% 37
2025
Q4
$1.76M Buy
8,520
+20
+0.2% +$3.96K 1.28% 16
2025
Q3
$1.58M Sell
8,500
-5
-0.1% -$857 1.9% 13
2025
Q2
$1.3M Sell
8,505
-116
-1% -$17.8K 1.62% 14
2025
Q1
$1.43M Buy
8,621
+2,498
+41% +$391K 1.98% 11
2024
Q4
$886K Sell
6,123
-142
-2% -$22K 0.05% 40
2024
Q3
$1.02M Buy
+6,265
New +$998K 1.47% 15

Other funds holding JNJ

Elser Financial Planning's JNJ Position: Q2 2026 in Review

Elser Financial Planning increased its Johnson & Johnson (JNJ) stake by 0.27% in Q2 2026, buying an estimated $5.36K and bringing the position to 8,544 shares worth $2.17M. The position accounts for 0.09% of the portfolio, ranked #36.

Elser Financial Planning first reported a position in JNJ in Q3 2024 and has held it in 8 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Elser Financial Planning held 8,544 shares of Johnson & Johnson worth $2.17M as of Q2 2026.
  • Elser Financial Planning bought 23 Johnson & Johnson shares in Q2 2026, an estimated $5.36K.
  • Johnson & Johnson made up 0.09% of Elser Financial Planning's portfolio in Q2 2026, its #36 holding.
  • Elser Financial Planning first reported a position in Johnson & Johnson in Q3 2024 and has held it in 8 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Elser Financial Planning's 13F filing for Q2 2026, filed 14 Jul 2026.